SonoVascular, Inc.
PrivateLast Round
Series A
Feb 3, 2026
Est. Valuation
$25M
Total Funding Raised
$9.31M
Company Overview
SonoVascular, Inc. is a medical device company developing an ultrasound-facilitated, thrombolytic-enhanced thrombectomy system for the treatment of venous and arterial thrombosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SonoVascular, Inc. Comparables
Compare SonoVascular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thrombolex, Inc. | 92% | |
| Caeli Vascular, Inc. | 90% | |
| Innova Vascular | 88% |
SonoVascular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 3, 2026 | ||||
| VC Round | Oct 29, 2024 | ||||
| Debt | May 16, 2024 | ||||
| Debt | Mar 31, 2024 | ||||
| Convertible Debt | Jun 30, 2023 | ||||
Seed | Mar 31, 2022 |
Key People
Founding team and executive leadership
SonoVascular, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Biotechnology Center | Debt |
| Wolfpack Investor Network | Convertible Debt, Seed, VC Round |
| Harbright Ventures | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 112% MoM, reaching 1K.
- Feb 4, 2026
Robert Ross, Founding Partner at Harbright Ventures, joins the board.
SonoVascular, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SonoVascular, Inc.'s valuation, stock price, and market status.
Is SonoVascular, Inc. a public or private company?
SonoVascular, Inc. is a private company.
What is the current stock price of SonoVascular, Inc.?
SonoVascular, Inc. is a private company, so its shares have no public market price. Caplight tracks SonoVascular, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SonoVascular, Inc. worth (valuation)?
SonoVascular, Inc.'s valuation is estimated at $25.0M based on funding round data.
Can I buy SonoVascular, Inc. stock?
SonoVascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SonoVascular, Inc.'s last funding round?
SonoVascular, Inc.'s most recent funding round was Series A on February 3, 2026.
Who are the main investors in SonoVascular, Inc.?
Key investors in SonoVascular, Inc. include Harbright Ventures.
Will SonoVascular, Inc. IPO soon?
No public IPO plans have been announced for SonoVascular, Inc..
How can I track SonoVascular, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SonoVascular, Inc.'s shares on secondary markets.